Evidence map›Paper›PMID 36854461›Full record

ArticleBMJ (Clinical research ed.)2023

Realistic expectations are key to realising the benefits of polygenic scores.

Amit Sud, Rachel H Horton, Aroon D Hingorani, Ioanna Tzoulaki, Clare Turnbull, Richard S Houlston, Anneke Lucassen

Registry-linked trialAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07039123 (Polygenic Risk Score to Optimize Primary Prevention in Intermediate Risk Population), which is not on this map. Cited by 49 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07039123 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Polygenic Risk Score to Optimize Primary Prevention in Intermediate Risk Population (PERSONAL)

TypeinterventionalSponsorUniversity of BernRan2025 to 2027Enrolled205ConditionsPrimary Prevention of Cardiovascular DiseaseArmsPolygenic Risk Score for Coronary Artery Disease (PRS-CAD), Standardized Risk Communication Tool (SCORE2)
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genomics in Health and Biomedicine.Advances in experimental medicine and biology · 2026
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. The value of large-scale programmes in human genomics.European journal of human genetics : EJHG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amit SudDivision of Genetics and Epidemiology, Institute of Cancer Research, London, UK amit.sud@icr.ac.uk.
Rachel H HortonWessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
Aroon D HingoraniInstitute of Cardiovascular Science, Faculty of Population Health, University College London, UK.
Ioanna TzoulakiDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.
Clare TurnbullDivision of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Richard S HoulstonDivision of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Anneke LucassenClinical Ethics, Law, and Society Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Funding

Cancer Research UK 25514Medical Research Council MR/S019669/1Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DiseaseMultifactorial InheritanceHumansRisk

Identifiers

PMID36854461
PMCPMC9973128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.